AGP Picks
View all

The best health and wellness news from Washington state

Provided by AGP

Healthy Living Washington: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Washington.

Press releases published on May 11, 2026

FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus
The Next Generation of the GLP-1 Revolution Is Already Underway
Fate Therapeutics Showcases FT819 Clinical Activity in SLE without the use of Conditioning Chemotherapy at the 2026 ASGCT Annual Meeting
The Future of Intoxication Detection May Be in Your Voice
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
Cruise Ship Virus Outbreaks Highlight Massive Emerging Demand for TOMI Environmental Solutions’ SteraMist Technology
Humanitarian organization CARE marks 80th anniversary of the original CARE PACKAGE®
维泰瑞隆SARM1抑制剂SIR2501获FDA快速通道资格,用于治疗化疗所致的周围神经病变(CIPN)
維泰瑞隆SARM1抑制劑SIR2501獲FDA快速通道資格,用於治療化療所致的周圍神經病變(CIPN)
Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026
Reunion Neuroscience to Present Full Data from RECONNECT Phase 2 Clinical Trial at Upcoming ASCP and APA Annual Meetings
ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform
CPTx appoints Edward Rebar as Chief Scientific Officer
Galectin Therapeutics Announces Publication of NAVIGATE Phase 2b Trial Results for Belapectin in the Journal of Hepatology
AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases
Jabez Biosciences Presents First-in-Human Pharmacokinetic and Pharmacodynamic Data for JBZ-001 at AACR Annual Meeting 2026
Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™
Exagen Inc. Reports First Quarter 2026 Results
First Participant Dosed in AskBio Phase 1/Phase 2 Gene Therapy Trial of AB-1009 for Late-Onset Pompe Disease (LOPD)
Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference

Share us

on your social networks:

Sign up for:

Healthy Living Washington

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.